Operating Margin of Adaptimmune Therapeutics PLC from 31 Dec 2016 to 30 Jun 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Adaptimmune Therapeutics PLC quarterly and annual Operating Margin in % history and change rate from 31 Dec 2016 to 30 Jun 2025.
  • Adaptimmune Therapeutics PLC Operating Margin for the quarter ending 30 Jun 2025 was -252%, a 363% decline year-over-year.
  • Adaptimmune Therapeutics PLC annual Operating Margin for 2024 was -39%, a 83% increase from 2023.
  • Adaptimmune Therapeutics PLC annual Operating Margin for 2023 was -232%, a 62% increase from 2022.
  • Adaptimmune Therapeutics PLC annual Operating Margin for 2022 was -604%, a 77% increase from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

Adaptimmune Therapeutics PLC Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q2 2025 -252% -198% -363% 01 Apr 2025 30 Jun 2025
Q1 2025 -36% +1002% +97% 01 Jan 2025 31 Mar 2025
Q4 2024 -39% +193% +83% 01 Oct 2024 31 Dec 2024
Q3 2024 -26% +139% +84% 01 Jul 2024 30 Sep 2024
Q2 2024 -54% +106% +66% 01 Apr 2024 30 Jun 2024
Q1 2024 -1039% -881% -558% 01 Jan 2024 31 Mar 2024
Q4 2023 -232% +372% +62% 01 Oct 2023 31 Dec 2023
Q3 2023 -165% +859% +84% 01 Jul 2023 30 Sep 2023
Q2 2023 -160% +1363% +89% 01 Apr 2023 30 Jun 2023
Q1 2023 -158% +1719% +92% 01 Jan 2023 31 Mar 2023
Q4 2022 -604% +2035% +77% 01 Oct 2022 31 Dec 2022
Q3 2022 -1024% +1493% +59% 01 Jul 2022 30 Sep 2022
Q2 2022 -1524% +896% +37% 01 Apr 2022 30 Jun 2022
Q1 2022 -1877% +2021% +52% 01 Jan 2022 31 Mar 2022
Q4 2021 -2639% +732% +22% 01 Oct 2021 31 Dec 2021
Q3 2021 -2517% +1448% +37% 01 Jul 2021 30 Sep 2021
Q2 2021 -2419% +3437% +59% 01 Apr 2021 30 Jun 2021
Q1 2021 -3898% +3311% +46% 01 Jan 2021 31 Mar 2021
Q4 2020 -3371% +9087% +73% 01 Oct 2020 31 Dec 2020
Q3 2020 -3965% +3573% +47% 01 Jul 2020 30 Sep 2020
Q2 2020 -5857% -5635% -2542% 01 Apr 2020 30 Jun 2020
Q1 2020 -7209% -7038% -4131% 01 Jan 2020 31 Mar 2020
Q4 2019 -12457% -12319% -8900% 01 Oct 2019 31 Dec 2019
Q3 2019 -7538% -7409% -5748% 01 Jul 2019 30 Sep 2019
Q2 2019 -222% -32% -17% 01 Apr 2019 30 Jun 2019
Q1 2019 -170% +32% +16% 01 Jan 2019 31 Mar 2019
Q4 2018 -138% +75% +35% 01 Oct 2018 31 Dec 2018
Q3 2018 -129% 01 Jul 2018 30 Sep 2018
Q2 2018 -190% 01 Apr 2018 30 Jun 2018
Q1 2018 -202% 01 Jan 2018 31 Mar 2018
Q4 2017 -213% 01 Oct 2017 31 Dec 2017

Adaptimmune Therapeutics PLC Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -39% +193% +83% 01 Jan 2024 31 Dec 2024
2023 -232% +372% +62% 01 Jan 2023 31 Dec 2023
2022 -604% +2035% +77% 01 Jan 2022 31 Dec 2022
2021 -2639% +732% +22% 01 Jan 2021 31 Dec 2021
2020 -3371% +9087% +73% 01 Jan 2020 31 Dec 2020
2019 -12457% -12319% -8900% 01 Jan 2019 31 Dec 2019
2018 -138% +75% +35% 01 Jan 2018 31 Dec 2018
2017 -213% +300% +58% 01 Jan 2017 31 Dec 2017
2016 -513% 01 Jan 2016 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.